Clinical trial
Safety Study of Tivanisiran to Treat Dry Eye
NCT05310422 is registered in ClinicalTrials.gov with Sylentis, S.A. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety Study of Tivanisiran to Treat Dry Eye
- Lead sponsor
- Sylentis, S.A.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- March 24, 2022
- Completion date
- October 11, 2023
- Enrollment
- 301 (actual)
- Sites
- 25
Conditions
As the registry lists them; a condition with its own page is linked.
dry eye disease